Autumn Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.20 M
- Company Age 33 Year, 4 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 0.50 M
- Revenue Growth -94.75%
- Profit Growth -118.45%
- Ebitda -112.93%
- Net Worth -0.30%
- Total Assets -18.49%
About Autumn Pharmachem
Autumn Pharmachem Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 October 1991 and has a history of 33 years and four months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹0.50 M.
Harendra Parikh and Ashokkumar Shah serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230MH1991PTC063606
-
Company No.
063606
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Oct 1991
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Autumn Pharmachem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harendra Parikh
|
Director | 15-Oct-1991 | Current |
|
Ashokkumar Shah
|
Director | 15-Oct-1991 | Current |
Financial Performance of Autumn Pharmachem.
Autumn Pharmachem Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 94.75% decrease. The company also saw a substantial fall in profitability, with a 118.45% decrease in profit. The company's net worth dipped by a decrease of 0.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Autumn Pharmachem?
In 2016, Autumn Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Advance Oleochem Private LimitedAshokkumar Shah is a mutual person
Charges (Loans)
₹0.50 M
₹0
Charges Breakdown by Lending Institutions
- The Menon Co-Op. Bank Ltd. : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Apr 1996 | The Menon Co-Op. Bank Ltd. | ₹0.50 M | Open |
How Many Employees Work at Autumn Pharmachem?
Unlock and access historical data on people associated with Autumn Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Autumn Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Autumn Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
